Literature DB >> 31301241

Severe brain involvement in 5q spinal muscular atrophy type 0.

Rodrigo H Mendonça1, Antônio J Rocha2, Andres Lozano-Arango3, Astry B Diaz3, Claudia Castiglioni4, André M S Silva1, Umbertina C Reed1, Leslie Kulikowski5, Ida Paramonov6, Ivon Cuscó6, Eduardo F Tizzano6, Edmar Zanoteli1.   

Abstract

Spinal muscular atrophy (SMA) type 0 is the most severe form of SMA, associated with the SMN1 gene and manifesting at birth. Most patients die in the first weeks of life. In this work, we present 3 patients with SMA type 0 who survived >1 year and presented diffuse and progressive brain abnormalities on magnetic resonance imaging, which are not usually seen in patients with SMA. Thus, severe brain involvement may likely be the full end manifestation of an already extreme SMA phenotype caused by substantial reduction of the SMN protein in the brain. ANN NEUROL 2019;86:458-462.
© 2019 American Neurological Association.

Entities:  

Year:  2019        PMID: 31301241     DOI: 10.1002/ana.25549

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

1.  The incidence of hydrocephalus among patients with and without spinal muscular atrophy (SMA): Results from a US electronic health records study.

Authors:  Ishir Bhan; Claudia Prada; Dayle James; Stacie Lallier; Anne Dilley; Susan Hall; Emma Viscidi; Nasha Wang; Maneesh Juneja; Corinne Makepeace; Karen Laird; Susan Eaton
Journal:  Orphanet J Rare Dis       Date:  2021-05-07       Impact factor: 4.123

2.  Spinal Muscular Atrophy in Blonde D'Aquitaine Calves Is Not Associated With FVT1 Gene Mutation.

Authors:  Giulia Cagnotti; Carlo Cantile; Stefania Chessa; Paola Sacchi; Antonio D'Angelo; Claudio Bellino
Journal:  Front Vet Sci       Date:  2020-06-23

3.  Cognitive performance of children with spinal muscular atrophy: A systematic review.

Authors:  Graziela Jorge Polido; Mariana Mangini Vaz de Miranda; Nelson Carvas; Rodrigo de Holanda Mendonça; Fátima Aparecida Caromano; Umbertina Conti Reed; Edmar Zanoteli; Mariana Callil Voos
Journal:  Dement Neuropsychol       Date:  2019 Oct-Dec

Review 4.  The First Orally Deliverable Small Molecule for the Treatment of Spinal Muscular Atrophy.

Authors:  Ravindra N Singh; Eric W Ottesen; Natalia N Singh
Journal:  Neurosci Insights       Date:  2020-11-23

Review 5.  Metabolic and Nutritional Issues Associated with Spinal Muscular Atrophy.

Authors:  Yang-Jean Li; Tai-Heng Chen; Yan-Zhang Wu; Yung-Hao Tseng
Journal:  Nutrients       Date:  2020-12-16       Impact factor: 5.717

6.  Spinal Muscular Atrophy and Communicating Hydrocephalus: A Novel or a Well-Established Rare Association?

Authors:  Fatimah Z Alkhars; Nabil Almajhad; Jaafer Al-Obaid; Fatimah Alghadeer; Ahmed Y Bo Ali
Journal:  Cureus       Date:  2020-11-11

7.  Practical guidelines to manage discordant situations of SMN2 copy number in patients with spinal muscular atrophy.

Authors:  Ivon Cuscó; Sara Bernal; Laura Blasco-Pérez; Maite Calucho; Laura Alias; Pablo Fuentes-Prior; Eduardo F Tizzano
Journal:  Neurol Genet       Date:  2020-11-18

8.  Functional Abnormalities of Cerebellum and Motor Cortex in Spinal Muscular Atrophy Mice.

Authors:  Arumugarajah Tharaneetharan; Madison Cole; Brandon Norman; Nayeli C Romero; Julian R A Wooltorton; Melissa A Harrington; Jianli Sun
Journal:  Neuroscience       Date:  2020-11-17       Impact factor: 3.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.